Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus

By sjmartinez • November 30, 2023

Hilder R, Tsai K, Quandt Z, Isaacs D, Drakaki A, Xing Y, In GK, Angell TE, Lechner MG. Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus. Front Endocrinol (Lausanne). 2023 Oct 31;14:1242830. doi: 10.3389/fendo.2023.1242830. PMID: 38027216; PMCID: PMC10643762.

Tags: autoimmune endocrinopathy, Endocrinology, General Internal Medicine, Hematology/Oncology, immune checkpoint inhibitor, immune related adverse events, Olive View DoM, Publications, safety, type 1 diabetes mellitus

Influence of Thyroglobulin Autoantibodies on Thyroglobulin Levels Measured by Different Methodologies: IMA, LC-MS/MS, and RIA

Petrovic I, LoPresti J, Fatemi S, Gianoukakis A, Burman K, Gomez-Lima CJ, Nguyen CT, Spencer CA. Influence of Thyroglobulin Autoantibodies on Thyroglobulin Levels Measured by[...]

Outcomes of Cytologically Indeterminate Thyroid Nodules Managed With Genomic Sequencing Classifier

Ahmadi S, Kotwal A, Bikas A, Xiang P, Goldner W, Patel A, Hughes EG, Longstaff X, Yeh MW, Livhits MJ. Outcomes of Cytologically Indeterminate Thyroid[...]

Phosphate Binder Impairs Levothyroxine Absorption in a Hypothyroid Patient With End-Stage Renal Disease

Ko M, Barai R, Brent G. Phosphate Binder Impairs Levothyroxine Absorption in a Hypothyroid Patient With End-Stage Renal Disease. Cureus. 2024 Oct 15;16(10):e71551. doi: 10.7759/cureus.71551.[...]